Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function

被引:30
作者
Simon, JHM
Miller, DL
Fouchier, RAM
Malim, MH [1 ]
机构
[1] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1006/viro.1998.9296
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The viral infectivity factor (Vif) of human immunodeficiency virus type-1 (HIV-1) functions at a late stage of the viral life cycle to confer infectivity on progeny virions. Although Vii is present in HIV-I particles, both the relevance of incorporation for function and the mechanism that underlies incorporation remain unresolved. Using matched T cell systems that express high or low levels of Vif, we demonstrate that the extent of Vif incorporation into virions varies in relation to cellular expression levels. Because viral infectivity is not affected by these variations, we suggest that the packaging of Vif is neither specific nor necessary for function. (C) 1998 Academic Press.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 43 条
[1]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[2]   Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations [J].
Bess, JW ;
Gorelick, RJ ;
Bosche, WJ ;
Henderson, LE ;
Arthur, LO .
VIROLOGY, 1997, 230 (01) :134-144
[3]   ASSEMBLY OF TYPE-C ONCORNAVIRUSES - MODEL [J].
BOLOGNESI, DP ;
MONTELARO, RC ;
FRANK, H ;
SCHAFER, W .
SCIENCE, 1978, 199 (4325) :183-186
[4]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY [J].
BORMAN, AM ;
QUILLENT, C ;
CHARNEAU, P ;
DAUGUET, C ;
CLAVEL, F .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2058-2067
[5]   Human immunodeficiency virus type 1 Vif protein binds to the Pr55(Gag) precursor [J].
Bouyac, M ;
Courcoul, M ;
Bertola, G ;
Baudat, Y ;
Gabuzda, D ;
Blanc, D ;
Chazal, N ;
Boulanger, P ;
Sire, J ;
Vigne, R ;
Spire, B .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9358-9365
[6]   Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A [J].
Braaten, D ;
Aberham, C ;
Franke, EK ;
Yin, L ;
Phares, W ;
Luban, J .
JOURNAL OF VIROLOGY, 1996, 70 (08) :5170-5176
[7]   Effect of cyclosporin A on the replication cycle of human immunodeficiency virus type 1 derived from H9 and Molt-4 producer cells [J].
Briggs, CJ ;
Tozser, J ;
Oroszlan, S .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :2963-2967
[8]   Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease [J].
Bukovsky, AA ;
Dorfman, T ;
Weimann, A ;
Gottlinger, HG .
JOURNAL OF VIROLOGY, 1997, 71 (02) :1013-1018
[9]   Characterization of human immunodeficiency virus type 1 Vif particle incorporation [J].
Camaur, D ;
Trono, D .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6106-6111
[10]  
CHECROUNE F, 1995, J ACQ IMMUN DEF SYND, V10, P1